Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
Canada
Monobasic

Health Canada 1987

Monobasic

Potassium Phosphate Monobasic Injection

176 MG / ML SolutionCanadaMarketedAuthorised 31 Dec 1987

Open in the registerAsk Osler about it

On this page

In other countries
Documents
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

Zetalax Clisma FosfatoItaly · Soluzione rettale · Zeta Farmaceutici S.P.A.Same form
Norgine Enema AdultSaudi Arabia · NorgineSame substance
Norgine Enema ChildrinSaudi Arabia · NorgineSame substance
DBL Potassium Dihydrogen Phosphate Concentrated InjectionSingapore · 1.361 g · injection · Pfizer Private LimitedSame substance

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Monobasic
Strength: 176 MG / ML
Dosage form: Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 31 Dec 1987
Registration: DIN 00711306
Marketing authorisation holder: Sandoz Canada Incorporated
ATC code: B05XA06
Group: Blood and blood-forming organs
Supply: ETHICAL